Human Pharmaceutical Portfolio

Razumab Injection

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthRanibizumab
ManufacturerIntas Pharmaceuticals Ltd
CategoryCritical Care
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.